Literature DB >> 30810668

"Vasopressor Support Sparing Strategies": a Concept to be Incorporated as a Paradigm in the Treatment of Vasodilatory Shock.

Paulo Roberto B Evora1, Domingo M Braile2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30810668      PMCID： PMC6385832          DOI： 10.21470/1678-9741-2019-0600

Source DB:  PubMed          Journal:  Braz J Cardiovasc Surg        ISSN： 0102-7638


× No keyword cloud information.
  6 in total

Review 1.  Catecholamine Vasopressor Support Sparing Strategies in Vasodilatory Shock.

Authors:  Mitchell S Buckley; Jeffrey F Barletta; Pamela L Smithburger; John J Radosevich; Sandra L Kane-Gill
Journal:  Pharmacotherapy       Date:  2019-01-02       Impact factor: 4.705

Review 2.  The guanylyl cyclase inhibition by MB as vasoplegic circulatory shock therapeutical target.

Authors:  P R B Evora; F Viaro
Journal:  Curr Drug Targets       Date:  2006-09       Impact factor: 3.465

3.  "Methylene blue should be relegated to rescue use and not as first-line therapy" cannot become a paradigm.

Authors:  Paulo R B Evora; Alfredo José Rodrigues; Andrea C Celotto
Journal:  J Cardiothorac Vasc Anesth       Date:  2013-12-02       Impact factor: 2.628

Review 4.  Catecholamines for inflammatory shock: a Jekyll-and-Hyde conundrum.

Authors:  Davide Tommaso Andreis; Mervyn Singer
Journal:  Intensive Care Med       Date:  2016-02-12       Impact factor: 17.440

Review 5.  Management of Refractory Vasodilatory Shock.

Authors:  Jacob C Jentzer; Saraschandra Vallabhajosyula; Ashish K Khanna; Lakhmir S Chawla; Laurence W Busse; Kianoush B Kashani
Journal:  Chest       Date:  2018-01-09       Impact factor: 9.410

6.  Impact of methylene blue in addition to norepinephrine on the intestinal microcirculation in experimental septic shock.

Authors:  Jordan Nantais; Tristan C Dumbarton; Nizam Farah; Alexander Maxan; Juan Zhou; Samuel Minor; Christian Lehmann
Journal:  Clin Hemorheol Microcirc       Date:  2014       Impact factor: 2.375
  6 in total
  1 in total

1.  After Thirty Years, We Still Cannot Understand Why Methylene Blue is not a Reference to Treat Vasoplegic Syndrome in Cardiac Surgery.

Authors:  Paulo Roberto B Evora; Ricardo O S Soares; Solange Bassetto; Maria Auxiliadora Martins; Fábio Luis da Silva Silva; Anibal Basile
Journal:  Braz J Cardiovasc Surg       Date:  2021-06-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.